Zhao B, Luo M, Wang A, Zhang W. MiR-182 antagonist alleviates glucocorticoid-induced secondary bone degeneration and osteoclast differentiation. Cell Mol Biol (Noisy-le-grand) [Internet]. 2022 Feb. 4 [cited 2024 Nov. 21];67(5):123-30. Available from: https://mail.cellmolbiol.org/index.php/CMB/article/view/4099